Library
The following publications describe the use of Fluotics’ automation consumables in the laboratory environment.
High-Throughput Fitness Experiments Reveal Specific Vulnerabilities of Human-Adapted Salmonella During Stress and Infection
High-throughput transposon screens map the gene networks that control Salmonella fitness across 25 host-associated stresses, revealing vulnerabilities specific to human-restricted serovars. Barcoded mutant libraries were plated on Fluotics 245 mm square Petri plates.
Preclinical Evaluation of Histone Deacetylase Inhibitors for Epigenetic Therapy of Diffuse Large B-Cell Lymphoma
This doctoral dissertation screens 41 newly synthesized histone deacetylase inhibitors across diffuse large B-cell lymphoma cell lines and identifies a lead candidate with selective activity in CREBBP-mutated cells. Automated liquid handling used a Fluotics CyBio TipTray (384/60 µL).
3D Collagen High-Throughput Screen Identifies Drugs that Induce Epithelial Polarity and Enhance Chemotherapy Response in Colorectal Cancer
A 3D collagen high-throughput screen of colorectal cancer cells found FDA-approved drugs that restore epithelial polarity, with azithromycin enhancing response to the chemotherapy irinotecan. The 384-well screen used Fluotics Agilent-compatible P30 tips (AGI-30.ST).
A High Throughput, High Content Screen for Non-Toxic Small Molecules that Reduce Levels of the Nuclear Lamina Protein Lamin B1
A high-content screen of roughly 97,000 compounds identified small molecules that lower Lamin B1, a protein whose overexpression drives adult-onset autosomal dominant leukodystrophy. Compound dilutions were prepared on an Agilent Bravo with Fluotics tips (AGI-30.NS).
A Novel Molecular Class that Recruits HDAC/MECP2 Complexes to PU.1 Motifs Reduces Neuroinflammation
Researchers screened for inhibitors of the Alzheimer’s risk transcription factor PU.1 and discovered A11, a molecule that reduces neuroinflammation in mouse models of Alzheimer’s disease. The compound dilution series ran on an Agilent Bravo with Fluotics tips (AGI-250.NS).
High-Throughput Repurposing Screen Reveals Compounds with Activity against Toxoplasma gondii Bradyzoites
A high-throughput drug-repurposing screen identifies compounds active against the dormant bradyzoite stage of Toxoplasma gondii, the form responsible for chronic infection. Parasite and compound suspensions were dispensed with Fluotics BXi-50F automation tips.
ICCB-Longwood Screening Facility
ICCB-Longwood uses an integrated linear platform that includes the Agilent 4-R BenchCel, Bravo and PlateLoc. This setup, contained in…
Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
ABSTRACT Cancer cell spheroids present a relevant in vitro model of avascular tumors for anti-cancer drug testing applications. A detailed…
Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
Abstract Background Chagas Disease, a WHO- and NIH-designated neglected tropical disease, is endemic in Latin America…
Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6a branch
Abstract The membrane-bound transcription factor ATF6α plays a cytoprotective role in the unfolded protein response (UPR), required for…
A genome wide RNA interference screening method to identify host factors that modulate Influenza A virus replication
The use of genome wide RNA interference (RNAi) screens to investigate host-viral interactions has revealed unexpected…









